Tag Archives: anthrax

Emergent will submit anthrax vaccine sBLA to FDA

emergent_logo

TweetEmergent BioSolutions, a global specialty pharmaceutical company, announced on Thursday that within the next two years it will submit a supplemental biologics license application for BioThrax, the company’s anthrax vaccine. Dan Abdun-Nabi, the president and CEO of Emergent BioSolutions, hosted … Read More »

Filed in Vaccine Development | Tagged , | Comments Off

Anthrax outbreak in Scotland called worst in 50 years

The 2009-2010 anthrax outbreak among drug users in Scotland has been called the largest in the United Kingdom in 50 years. Read More »

Filed in News | Tagged | Comments Off

Progress reported on second-gen anthrax vaccine

Further development progress was announced this week by PharmAthene for its second generation rPA anthrax vaccine SparVax. Read More »

Filed in Medical Countermeasures, News | Tagged | Comments Off

Biden’s brother released from hospital after powder scare

Francis Biden, the brother of Vice President Joe Biden, was hospitalized overnight after a white powder from a manila envelope sent from India fell onto his skin upon opening the mail. Read More »

Filed in News, U.S. Government | Tagged | Comments Off

Calif. man charged over anthrax hoax letters

A California man was recently charged with two felonies for sending letters filled with a white powder to the city halls in San Carlos and South San Francisco over the summer. Read More »

Filed in News, U.S. Government | Tagged | Comments Off

Emergent BioSolutions submits proposal to develop new anthrax vaccine

ROCKVILLE, Md. Read More »

Filed in News, Vaccine Development | Tagged , , | Comments Off

Government extends deadline for plans to develop anthrax rPA vaccine

ROCKVILLE, Md. Read More »

Filed in News, Vaccine Development | Tagged , , | Comments Off

Emergent BioSolutions announces start of anthrax treatment trial

ROCKVILLE, Md. Read More »

Filed in News, Vaccine Development | Tagged , , | Comments Off

Emergent BioSolutions acquires monoclonal anthrax product candidate

Md. governor praises Emergent BioSolutions

Emergent BioSolutions acquires manufacturing facility from MdBio

FDA: Vaccine safe, effective to prevent anthrax regardless of route of exposure

Emergent BioSolutions reports financial results for 3rd quarter

FDA panel wants more data on anthrax drug

Formulation used to fight bio-terrorism released for commercial use